Editorial comment on: daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance.
Eardley
Ian
I
D000818:Animals; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D004727:Endothelium / Q000187:drug effects* / Q000503:physiopathology*; D007333:Insulin Resistance; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D011687:Purines / Q000008:administration & dosage; D051381:Rats; D017208:Rats, Wistar; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage*
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate